BioSig Technologies, Inc. (BSGM)
- Previous Close
1.3000 - Open
1.3100 - Bid 1.3300 x 700
- Ask 1.3900 x 400
- Day's Range
1.2800 - 1.3900 - 52 Week Range
0.2620 - 16.5000 - Volume
95,064 - Avg. Volume
1,188,053 - Market Cap (intraday)
15.342M - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
-- - EPS (TTM)
-3.9500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
33.75
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
www.biosig.comRecent News: BSGM
Performance Overview: BSGM
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BSGM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BSGM
Valuation Measures
Market Cap
15.34M
Enterprise Value
15.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
559.55
Price/Book (mrq)
--
Enterprise Value/Revenue
866.97
Enterprise Value/EBITDA
-0.55
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-603.25%
Return on Equity (ttm)
--
Revenue (ttm)
18k
Net Income Avi to Common (ttm)
-29.05M
Diluted EPS (ttm)
-3.9500
Balance Sheet and Cash Flow
Total Cash (mrq)
190k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-7.66M